Verisante Technology Inc (VRSEF) 0.0812 $VRSEF
Asian Diagnostic Device Market 2015-2019: Analysis of Diagnostic Device (Dermatoscope, Microscope, Imaging Techniques) & Treatment Devices (Liposuction, Microdermabrasion, Lasers)
M2 - Thu May 07, 10:22AM CDT
Research and Markets (http://www.researchandmarkets.com/research/t9l5mt/asian_dermatology) has announced the addition of the "Asian Dermatology Diagnostic Devices Market by Diagnostic Device, by Treatment Device, by Application - Forecast to 2019" report to their offering. The Asian dermatology diagnostic devices market is estimated to grow at a CAGR of 6.5% from 2014 to 2019 Although mature markets such as China and Japan hold larger shares in the Asian Ddermatology diagnostic devices market, the Indian region is expected to grow at the highest CAGR of 7.3%. The growth of the Asian dermatology diagnostic devices market is driven by factors such as rising skin disorders, demand for diagnosis by baby boomers, demand for dermatologists, and technology advantages. However, factors such as a lack of awareness and dermatology care are hindering the growth of this market. The market, based on type of product, includes dermatoscopes, imaging techniques, and microscopes. Imaging techniques held the highest share in the market, growing at a CAGR of 7.0% during the forecast period. This is due to their use as in vivo tools; they also help in the detection of later stages of skin disorders. Geographically, China is estimated to have the largest share of 31.0% of the Asian Dermatology diagnostic devices market in 2014, followed by Japan. The dermatology diagnostic devices market in the China region is primarily driven by the increasing prevalence of skin disorders such as melanoma and psoriasis. The fastest-growing Indian market is driven by increasing insurance coverage and the awareness of various skin disorders in this region. The Asian dermatology diagnostic devices market is a competitive market, with a number of players. As of 2014, the Asian Dermatology diagnostic devices market is estimated to be dominated by Heine Optotechnik (Germany), Optomed Oy (Finland), FotoFinder Systems (Germany), Michelson Diagnostics (U.K.), GE Healthcare (U.K.), Philips Healthcare (Netherlands), Welch Allyn (U.S.), Carl Zeiss Meditec, Inc. (U.S.), Hitachi (Japan), Leica Microsystems (Germany), Olympus (Japan), Toshiba Medical Systems (Japan), and Siemens Healthcare (Germany). Companies Mentioned - AMD Global Telemedicine, Inc. - Bruker Corporation - Carl Zeiss - FEI Company - Fotofinder Systems Gmbh - GE Healthcare - Heine Optotechnik - Leica Microsystems - MELA Sciences, Inc. - Michelson Diagnostics Ltd. - Nikon Corporation - Philips Healthcare - Photomedex, Inc. - Siemens Healthcare - Toshiba Medical Systems - Verisante Technology, Inc. - Welch Allyn For more information visit http://www.researchandmarkets.com/research/t9...ermatology
MELA: 1.43 (-0.02), FEIC: 78.14 (+0.79)
Asian Dermatology Devices (Treatment & Diagnostic) Market by Type, by End User - Forecast to 2019
M2 - Fri May 01, 5:35AM CDT
Research and Markets (http://www.researchandmarkets.com/research/b8f54g/asian_dermatology) has announced the addition of the "Asian Dermatology Devices Market by Type, by End User - Forecast to 2019" report to their offering. The Asian Dermatology Devices market is estimated to grow at a CAGR of 11.3% from 2014 to 2019. China holds a larger share in the Dermatology devices market around 28.8% in 2014 followed by Japan. The Asian Dermatology Devices market holds a high potential for growth in future due to a number of forces favoring this market. These include increasing number of people suffering from skin disorders, demand for devices at a lower cost and increasing awareness aesthetic procedures. However, price sensitive market is having an adverse effect on the dermatology devices market. In this report, the Asian Dermatology devices market is broadly classified on the basis of product types, end users. The products segment is classified into Dermatology treatment devices and Dermatology diagnostic devices. Based on end users, the Dermatology devices market is categorized into Hospitals and Clinics. Geographically the market is divided into eight countries, namely Japan, China, India, Korea, Singapore, Malaysia, Indonesia and Rest of Asia (RoE). China is estimated to command the largest share of 28.7% of the Asian Dermatology Devices market in 2014, followed by Japan. Japan is estimated to grow at a CAGR of 7.9% during the forecast period from 2014 to 2019. Certain factors that influence the demand for the Asian dermatology devices market include the increasing number of people who suffer from skin disorders and the demand for devices at a lower cost. Thus, world-class manufacturers are coming up with devices at a lower price and concentrate on the Asian region to expand their business and geographical reach. Countries in the Asian region, namely India and China have a tropical climate, making the inhabitants of this region extremely prone to sun exposure, particularly skin tanning. Thus, there is an increase in the demand for dermatological treatments that have an impact on the growth of the dermatology diagnostic devices market in Asia. The number of skin cancer cases in Singapore has been increasing. There were 2,819 cases of skin cancer in Singapore from 2008 to 2012, among which 83.0% were Chinese, according to the National Skin Centre, followed by Malays recording 4.5% of the cases. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Market Overview 5 Asian Dermatology Devices Market, By Type 6 Asian Dermatology Devices Market, By End-User 7 Asian Dermatology Devices Market, By Geography 8 Asian Dermatology Devices Market: Competitive Landscape 9 Asian Dermatology Devices Market: Company Profiles - ALMA Lasers, Ltd. - Ambicare Health Ltd. - amd Global Telemedicine Inc - Applisonix Ltd - Biolitec0020AG - Carl Zeiss - Cynosure, Inc. - Ellipse A/S - fei Company - Fotofinder Systems GMBH - Genesis Biosystems. - Heine Optotechnik - Leica Microsystems - Lumenis Ltd. - Mela Sciences, Inc. - Michelson Diagnostics Ltd - Nikon Corporation - Photomedex, Inc. - Solta Medical, Llc. (Division of Valeant Pharmaceuticals North America, Llc.) - Syneron Medical Ltd - Verisante Technology, Inc. For more information visit http://www.researchandmarkets.com/research/b8...ermatology
ELOS: 11.76 (-0.19), CYNO: 35.65 (+0.28), LMNS: 11.15 (-0.02)
North American Dermatology Devices (Dermatology Treatment Devices, Dermatology Diagnostic Devices) Market 2015 - Forecast to 2019
M2 - Fri Apr 24, 5:31AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bk922d/north_american) has announced the addition of the "North American Dermatology Devices Market by Type (Dermatology Treatment Devices, Dermatology Diagnostic Devices) - Forecast to 2019" report to their offering. The North American dermatology diagnostic devices market is estimated to grow at a CAGR of 7.9% from 2014 to 2019 Although mature markets (the U.S. and Canada) command larger shares in the dermatology diagnostic devices market, Mexico is expected to grow at the highest CAGR of 9.8% during the forecast period. The growth of the dermatology diagnostic devices market is driven by factors such as rising incidences of skin disorders, increasing demand for diagnosis by baby boomers, need for more dermatologists, and technological advancements. However, factors such as lack of awareness, competitive pricing, and lack of dermatology care are hindering the growth of this market. In this report, the North American dermatology diagnostic devices market has been broadly classified on the basis of types. This segment includes dermatoscopes, imaging techniques, and microscopes. The imaging techniques segment commands the largest share of the dermatology diagnostic devices market, growing at a CAGR of 8.0% during the forecast period (2014 to 2019). This large share is mainly due to the fact that imaging techniques are generally in vivo tools and helps in the detection of later stages of skin disorders. The U.S commanded the largest share of 89.3% of the North American dermatology diagnostic devices market in 2014, followed by Canada. The dermatology diagnostic devices market in the U.S. is primarily driven by the increasing demand from baby boomers and increasing insurance coverage for citizens due to increasing employment. Mexico is the fastest-growing segment in the North American region, at a CAGR of 9.8% during the forecast period. This is due to the increasing insurance coverage and awareness of various skin disorders in this region. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Market Overview 5 North America Dermatology Devices Market, By Type 6 North America Dermatology Devices Market, By Geography 7 North America Dermatology Devices Market: Competitive Landscape 8 Dermatology Devices Market, By Company - Alma Lasers, Ltd. - Ambicare Health Ltd - Amd Global Telemedicine Inc. - Applisonix Ltd. - Biolitec Ag - Carl Zeiss Meditec - Cutera, Inc. - Cynosure, Inc. - Ellipse A/S - Fei Company - Fotofinder Systems Gmbh - Genesis Biosystems - Leica Microsystems - Lumenis Ltd. - Mela Sciences, Inc. - Michelson Diagnostics Ltd. - Nikon Corporation - Photomedex, Inc. - Solta Medical, - Syneron Medical Ltd. - Verisante Technology, Inc. For more information visit http://www.researchandmarkets.com/research/bk...h_american
ELOS: 11.76 (-0.19), CYNO: 35.65 (+0.28), LMNS: 11.15 (-0.02)
Global Dermatology Diagnostic Devices Market 2015-2019 - Type (Imaging Techniques, Dermatoscopes, Microscopes) & End-User (Hospitals, Clinics) Analysis
M2 - Wed Apr 22, 9:02AM CDT
Research and Markets (http://www.researchandmarkets.com/research/5qq5d4/dermatology) has announced the addition of the "Dermatology Diagnostic Devices Market by Product [Imaging Techniques (OCT, Ultrasound, MRI, CT), Dermatoscopes (Traditional Dermatoscopes, Digital Dermatoscopes), Microscopes], by End-User (Hospitals, Clinics) - Global Forecast to 2019" report to their offering. The global dermatology diagnostic devices market is estimated to grow at a CAGR of 8.2% from 2014 to 2019 North America and Europe hold larger shares in the global dermatology diagnostic devices market. The growth of the global dermatology diagnostic devices market is mainly attributed to a wide range of factors, such as increasing incidence of skin disorders, growing demand of dermatologists, and technological advancements made in the field of medical science. However, lack of awareness and poor dermatology care are certain factors restraining the growth of this market. In this report, the global dermatology diagnostic devices market has been broadly classified on the basis of types. The type segment includes dermatoscope, imaging technique, and microscope. The imaging technique has the highest market share in the diagnostic device market, registering a CAGR of 8.5% during the forecast period. This growth is mainly triggered by the increasing significance of dermatology techniques and advantages it offers with respect to early detection of skin disorders. Geographically, North America is estimated to have the largest share of 37.1% in the global dermatology diagnostic devices market in 2014, followed by Europe. The dermatology diagnostic devices market in North America is primarily driven by the increasing prevalence of skin disorders, such as melanoma and psoriasis, and highly organized health care infrastructure and guidelines. The European region is the fastest growing region progressing at a CAGR of 9.6% from 2014 to 2019, owing to the increase in insurance coverage, incessant rise in geriatric population, and growing awareness about various skin disorders. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Market Overview 5 Global Dermatology Diagnostic Devices Market, By Product 6 Global Dermatology Diagnostic Devices Market, By Geography 7 Global Dermatology Diagnostic Devices Market, By End User 8 Global Dermatology Diagnostic Devices Market: Competitive Landscape 9 Global Dermatology Diagnostic Devices Market, By Company - AMD Global Telemedicine Inc - Bruker Corporation - Carl Zeiss - FEI Company - Fotofinder Systems Gmbh - GE Healthcare - Heine Optotechnik - Leica Microsystems - Mela Sciences, Inc. - Michelson Diagnostics Ltd - Nikon Corporation - Philips Healthcare - Photomedex, Inc. - Seimens Healthcare - Toshiba Medical Systems - Verisante Technology, Inc. - Welch Allyn For more information visit http://www.researchandmarkets.com/research/5q...ermatology
FEIC: 78.14 (+0.79)
Verisante Obtains Mexican Approval
Marketwired - Thu Mar 12, 9:02AM CDT
Verisante Technology, Inc. (TSX VENTURE: VRS)(OTCQX: VRSEF) (the "Company" or "Verisante"
, a leader in skin cancer detection technology, announced today that it has received regulatory approval from the Federal Commission for Protection against Sanitary Risks (COFEPRIS), a division within the Mexican Ministry of Health, to market and sell Aura(TM), a device for the detection of skin cancer, in Mexico.
VRS.VN: 0.100 (+0.010)
Verisante Technology, Inc. Announces Equipment Loan to Further Collaboration With Key Chinese Laboratory
Marketwired - Wed Feb 18, 9:01AM CST
Verisante Technology, Inc. (TSX VENTURE: VRS)(OTCQX: VRSEF) (the "Company" or "Verisante" , a leader in cancer detection technology, announced today it has expanded its collaboration with Fujian Normal University in China (the "University" .
VRS.VN: 0.100 (+0.010)
Verisante Technology, Inc. Announces Brain Tumour Study in the UK
Marketwired - Tue Jan 13, 8:30AM CST
Verisante Technology, Inc. (TSX VENTURE: VRS)(OTCQX: VRSEF) (the "Company" or "Verisante" , a leader in cancer detection technology, announced today it has entered into a collaboration with the BC Cancer Agency and Imperial College Healthcare NHS Trust to develop a new application for the Company's exclusively licensed platform technology.
VRS.VN: 0.100 (+0.010)
Verisante Technology, Inc. Announced Non-Brokered Private Placement and Year End Operational Update
Marketwired - Wed Dec 31, 8:31AM CST
Verisante Technology, Inc. (TSX VENTURE: VRS)(OTCQX: VRSEF) (the "Company" or "Verisante" , a leader in cancer detection technology, today announced it has closed a non-brokered private placement of 3,888,889 common shares at a price of $0.09 per share for gross proceeds of $350,000.
VRS.VN: 0.100 (+0.010)
North American Dermatology Diagnostic Devices Market Report 2014
M2 - Wed Dec 17, 6:32AM CST
Research and Markets (http://www.researchandmarkets.com/research/ddkrdp/micro_market) has announced the addition of the "Micro Market Monitor: North American Dermatology Diagnostic Devices Market" report to their offering. North America is considered to be the largest market in the dermatology diagnostic devices market segment, which is anticipated to grow at a CAGR of 9.6% from 2012 to 2013. Cosmetic surgeries and dermatological treatment is progressing steadily, which has resulted in fueling the overall demand of the dermatology diagnostic devices market. The main purpose of these dermatology devices is to assist in identifying and monitoring a patient's skin condition. With the growing awareness of skin disorders among the recent population, there is a rising incidence of dermatological procedures in the market. This has significantly laid a positive impact on the growing dependence of these innovative dermatological diagnostic techniques. The growing incidence of non-invasive aesthetic procedures have progressed the demand of dermatological diagnostic devices market in North America. Several other factors that have added to this growing demand are the prevalence of skin disorders, such as several tanning issues caused due to sun exposure, skin cancer, psoriasis, varicose veins, pigmentation, and vascular lesions. Advancements made in the field of dermatology have also resulted in the emergence of state-of-the-art diagnostic devices that deliver quick and accurate results. This huge demand of highly sophisticated diagnostic devices required to effectively examine patients and recommend necessary treatment measures have further influenced the North America dermatology diagnostic devices market to a large extent. Key Topics Covered: 1. Executive Summary 2. Introduction 3. Research Methodology 4. Market Overview 5. U.S. Dermatology Diagnostic Devices By Types 6. U.S. Dermatology Treatmetn Devices By Types 7. Company Profiles - Alma Lasers, Ltd. - Ambicare Health Ltd. - Amd Global Telemedicine Inc - Applisonix Ltd - Biolitec Ag - Carl Zeiss - Cutera, Inc. - Cynosure, Inc. - Ellipse A/S - Fei Company - Fotofinder Systems Gmbh - Genesis Biosystems - Leica Microsystems - Lumenis Ltd. - Michelson Diagnostics Ltd. - Nikon Corporation - Mela Sciences, Inc. - Verisante Technology, Inc. - Syneron Medical Ltd. - Heine Optotechnik - Solta Medical, A Division Of Valeant Pharmaceuticals North America, Llc. - Photomedex, Inc. For more information visit http://www.researchandmarkets.com/research/dd...cro_market
ELOS: 11.76 (-0.19), CYNO: 35.65 (+0.28), LMNS: 11.15 (-0.02)
Verisante Technology, Inc. to Present at 2nd Emerging Medical Technologies (EMT) Summit
Marketwired - Mon Nov 10, 9:01AM CST
Verisante Technology, Inc. (TSX VENTURE: VRS)(OTCQX: VRSEF) (the "Company" or "Verisante" , a leader in cancer detection technology, today announced that Thomas Braun, President & CEO, will present at the upcoming Emerging Medical Technologies (EMT) Summit in San Francisco on November 11, 2014 at the Sofitel Hotel San Francisco Bay.
VRS.VN: 0.100 (+0.010)
Verisante Technology, Inc. Announces Non Brokered Private Placement
Marketwired - Wed Oct 15, 11:36AM CDT
Verisante Technology, Inc. (TSX VENTURE: VRS)(OTCQX: VRSEF) (the "Company" or "Verisante" , a leader in cancer detection technology, announced today it has closed a non-brokered private placement of 2,500,000 common shares at a price of $0.14 per share for gross proceeds of $350,000.
VRS.VN: 0.100 (+0.010)
Verisante Technology, Inc. Announces Submission to the FDA for Aura(TM), a Skin Cancer Detection Device
Marketwire - Wed Oct 01, 9:01AM CDT
Verisante Technology, Inc. (TSX VENTURE: VRS)(OTCQX: VRSEF) (the "Company" or "Verisante" , a leader in cancer detection technology, announced today it has initiated communications with the Food and Drug Administration ("FDA" in the United States for the approval of Aura(TM), a device for the detection of skin cancer.
VRS.VN: 0.100 (+0.010)
Verisante Technology, Inc. Announces Re-Negotiated Letter of Intent for Equity Stake in Chinese Company
Marketwire - Tue Sep 30, 9:01AM CDT
Verisante Technology, Inc. (TSX VENTURE: VRS)(OTCQX: VRSEF) (the "Company" or "Verisante" , a leader in cancer detection technology, announced today it has renegotiated a Letter of Intent between the Company and strategic partner (the "Partner" in the People's Republic of China, which terms were previously announced on June 25, 2014.
VRS.VN: 0.100 (+0.010)
Asian Diagnostic Device Market 2015-2019: Analysis of Diagnostic Device (Dermatoscope, Microscope, Imaging Techniques) & Treatment Devices (Liposuction, Microdermabrasion, Lasers)
M2 - Thu May 07, 10:22AM CDT
Research and Markets (http://www.researchandmarkets.com/research/t9l5mt/asian_dermatology) has announced the addition of the "Asian Dermatology Diagnostic Devices Market by Diagnostic Device, by Treatment Device, by Application - Forecast to 2019" report to their offering. The Asian dermatology diagnostic devices market is estimated to grow at a CAGR of 6.5% from 2014 to 2019 Although mature markets such as China and Japan hold larger shares in the Asian Ddermatology diagnostic devices market, the Indian region is expected to grow at the highest CAGR of 7.3%. The growth of the Asian dermatology diagnostic devices market is driven by factors such as rising skin disorders, demand for diagnosis by baby boomers, demand for dermatologists, and technology advantages. However, factors such as a lack of awareness and dermatology care are hindering the growth of this market. The market, based on type of product, includes dermatoscopes, imaging techniques, and microscopes. Imaging techniques held the highest share in the market, growing at a CAGR of 7.0% during the forecast period. This is due to their use as in vivo tools; they also help in the detection of later stages of skin disorders. Geographically, China is estimated to have the largest share of 31.0% of the Asian Dermatology diagnostic devices market in 2014, followed by Japan. The dermatology diagnostic devices market in the China region is primarily driven by the increasing prevalence of skin disorders such as melanoma and psoriasis. The fastest-growing Indian market is driven by increasing insurance coverage and the awareness of various skin disorders in this region. The Asian dermatology diagnostic devices market is a competitive market, with a number of players. As of 2014, the Asian Dermatology diagnostic devices market is estimated to be dominated by Heine Optotechnik (Germany), Optomed Oy (Finland), FotoFinder Systems (Germany), Michelson Diagnostics (U.K.), GE Healthcare (U.K.), Philips Healthcare (Netherlands), Welch Allyn (U.S.), Carl Zeiss Meditec, Inc. (U.S.), Hitachi (Japan), Leica Microsystems (Germany), Olympus (Japan), Toshiba Medical Systems (Japan), and Siemens Healthcare (Germany). Companies Mentioned - AMD Global Telemedicine, Inc. - Bruker Corporation - Carl Zeiss - FEI Company - Fotofinder Systems Gmbh - GE Healthcare - Heine Optotechnik - Leica Microsystems - MELA Sciences, Inc. - Michelson Diagnostics Ltd. - Nikon Corporation - Philips Healthcare - Photomedex, Inc. - Siemens Healthcare - Toshiba Medical Systems - Verisante Technology, Inc. - Welch Allyn For more information visit http://www.researchandmarkets.com/research/t9...ermatology
MELA: 1.43 (-0.02), FEIC: 78.14 (+0.79)
Asian Dermatology Devices (Treatment & Diagnostic) Market by Type, by End User - Forecast to 2019
M2 - Fri May 01, 5:35AM CDT
Research and Markets (http://www.researchandmarkets.com/research/b8f54g/asian_dermatology) has announced the addition of the "Asian Dermatology Devices Market by Type, by End User - Forecast to 2019" report to their offering. The Asian Dermatology Devices market is estimated to grow at a CAGR of 11.3% from 2014 to 2019. China holds a larger share in the Dermatology devices market around 28.8% in 2014 followed by Japan. The Asian Dermatology Devices market holds a high potential for growth in future due to a number of forces favoring this market. These include increasing number of people suffering from skin disorders, demand for devices at a lower cost and increasing awareness aesthetic procedures. However, price sensitive market is having an adverse effect on the dermatology devices market. In this report, the Asian Dermatology devices market is broadly classified on the basis of product types, end users. The products segment is classified into Dermatology treatment devices and Dermatology diagnostic devices. Based on end users, the Dermatology devices market is categorized into Hospitals and Clinics. Geographically the market is divided into eight countries, namely Japan, China, India, Korea, Singapore, Malaysia, Indonesia and Rest of Asia (RoE). China is estimated to command the largest share of 28.7% of the Asian Dermatology Devices market in 2014, followed by Japan. Japan is estimated to grow at a CAGR of 7.9% during the forecast period from 2014 to 2019. Certain factors that influence the demand for the Asian dermatology devices market include the increasing number of people who suffer from skin disorders and the demand for devices at a lower cost. Thus, world-class manufacturers are coming up with devices at a lower price and concentrate on the Asian region to expand their business and geographical reach. Countries in the Asian region, namely India and China have a tropical climate, making the inhabitants of this region extremely prone to sun exposure, particularly skin tanning. Thus, there is an increase in the demand for dermatological treatments that have an impact on the growth of the dermatology diagnostic devices market in Asia. The number of skin cancer cases in Singapore has been increasing. There were 2,819 cases of skin cancer in Singapore from 2008 to 2012, among which 83.0% were Chinese, according to the National Skin Centre, followed by Malays recording 4.5% of the cases. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Market Overview 5 Asian Dermatology Devices Market, By Type 6 Asian Dermatology Devices Market, By End-User 7 Asian Dermatology Devices Market, By Geography 8 Asian Dermatology Devices Market: Competitive Landscape 9 Asian Dermatology Devices Market: Company Profiles - ALMA Lasers, Ltd. - Ambicare Health Ltd. - amd Global Telemedicine Inc - Applisonix Ltd - Biolitec0020AG - Carl Zeiss - Cynosure, Inc. - Ellipse A/S - fei Company - Fotofinder Systems GMBH - Genesis Biosystems. - Heine Optotechnik - Leica Microsystems - Lumenis Ltd. - Mela Sciences, Inc. - Michelson Diagnostics Ltd - Nikon Corporation - Photomedex, Inc. - Solta Medical, Llc. (Division of Valeant Pharmaceuticals North America, Llc.) - Syneron Medical Ltd - Verisante Technology, Inc. For more information visit http://www.researchandmarkets.com/research/b8...ermatology
ELOS: 11.76 (-0.19), CYNO: 35.65 (+0.28), LMNS: 11.15 (-0.02)
North American Dermatology Devices (Dermatology Treatment Devices, Dermatology Diagnostic Devices) Market 2015 - Forecast to 2019
M2 - Fri Apr 24, 5:31AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bk922d/north_american) has announced the addition of the "North American Dermatology Devices Market by Type (Dermatology Treatment Devices, Dermatology Diagnostic Devices) - Forecast to 2019" report to their offering. The North American dermatology diagnostic devices market is estimated to grow at a CAGR of 7.9% from 2014 to 2019 Although mature markets (the U.S. and Canada) command larger shares in the dermatology diagnostic devices market, Mexico is expected to grow at the highest CAGR of 9.8% during the forecast period. The growth of the dermatology diagnostic devices market is driven by factors such as rising incidences of skin disorders, increasing demand for diagnosis by baby boomers, need for more dermatologists, and technological advancements. However, factors such as lack of awareness, competitive pricing, and lack of dermatology care are hindering the growth of this market. In this report, the North American dermatology diagnostic devices market has been broadly classified on the basis of types. This segment includes dermatoscopes, imaging techniques, and microscopes. The imaging techniques segment commands the largest share of the dermatology diagnostic devices market, growing at a CAGR of 8.0% during the forecast period (2014 to 2019). This large share is mainly due to the fact that imaging techniques are generally in vivo tools and helps in the detection of later stages of skin disorders. The U.S commanded the largest share of 89.3% of the North American dermatology diagnostic devices market in 2014, followed by Canada. The dermatology diagnostic devices market in the U.S. is primarily driven by the increasing demand from baby boomers and increasing insurance coverage for citizens due to increasing employment. Mexico is the fastest-growing segment in the North American region, at a CAGR of 9.8% during the forecast period. This is due to the increasing insurance coverage and awareness of various skin disorders in this region. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Market Overview 5 North America Dermatology Devices Market, By Type 6 North America Dermatology Devices Market, By Geography 7 North America Dermatology Devices Market: Competitive Landscape 8 Dermatology Devices Market, By Company - Alma Lasers, Ltd. - Ambicare Health Ltd - Amd Global Telemedicine Inc. - Applisonix Ltd. - Biolitec Ag - Carl Zeiss Meditec - Cutera, Inc. - Cynosure, Inc. - Ellipse A/S - Fei Company - Fotofinder Systems Gmbh - Genesis Biosystems - Leica Microsystems - Lumenis Ltd. - Mela Sciences, Inc. - Michelson Diagnostics Ltd. - Nikon Corporation - Photomedex, Inc. - Solta Medical, - Syneron Medical Ltd. - Verisante Technology, Inc. For more information visit http://www.researchandmarkets.com/research/bk...h_american
ELOS: 11.76 (-0.19), CYNO: 35.65 (+0.28), LMNS: 11.15 (-0.02)
Global Dermatology Diagnostic Devices Market 2015-2019 - Type (Imaging Techniques, Dermatoscopes, Microscopes) & End-User (Hospitals, Clinics) Analysis
M2 - Wed Apr 22, 9:02AM CDT
Research and Markets (http://www.researchandmarkets.com/research/5qq5d4/dermatology) has announced the addition of the "Dermatology Diagnostic Devices Market by Product [Imaging Techniques (OCT, Ultrasound, MRI, CT), Dermatoscopes (Traditional Dermatoscopes, Digital Dermatoscopes), Microscopes], by End-User (Hospitals, Clinics) - Global Forecast to 2019" report to their offering. The global dermatology diagnostic devices market is estimated to grow at a CAGR of 8.2% from 2014 to 2019 North America and Europe hold larger shares in the global dermatology diagnostic devices market. The growth of the global dermatology diagnostic devices market is mainly attributed to a wide range of factors, such as increasing incidence of skin disorders, growing demand of dermatologists, and technological advancements made in the field of medical science. However, lack of awareness and poor dermatology care are certain factors restraining the growth of this market. In this report, the global dermatology diagnostic devices market has been broadly classified on the basis of types. The type segment includes dermatoscope, imaging technique, and microscope. The imaging technique has the highest market share in the diagnostic device market, registering a CAGR of 8.5% during the forecast period. This growth is mainly triggered by the increasing significance of dermatology techniques and advantages it offers with respect to early detection of skin disorders. Geographically, North America is estimated to have the largest share of 37.1% in the global dermatology diagnostic devices market in 2014, followed by Europe. The dermatology diagnostic devices market in North America is primarily driven by the increasing prevalence of skin disorders, such as melanoma and psoriasis, and highly organized health care infrastructure and guidelines. The European region is the fastest growing region progressing at a CAGR of 9.6% from 2014 to 2019, owing to the increase in insurance coverage, incessant rise in geriatric population, and growing awareness about various skin disorders. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Market Overview 5 Global Dermatology Diagnostic Devices Market, By Product 6 Global Dermatology Diagnostic Devices Market, By Geography 7 Global Dermatology Diagnostic Devices Market, By End User 8 Global Dermatology Diagnostic Devices Market: Competitive Landscape 9 Global Dermatology Diagnostic Devices Market, By Company - AMD Global Telemedicine Inc - Bruker Corporation - Carl Zeiss - FEI Company - Fotofinder Systems Gmbh - GE Healthcare - Heine Optotechnik - Leica Microsystems - Mela Sciences, Inc. - Michelson Diagnostics Ltd - Nikon Corporation - Philips Healthcare - Photomedex, Inc. - Seimens Healthcare - Toshiba Medical Systems - Verisante Technology, Inc. - Welch Allyn For more information visit http://www.researchandmarkets.com/research/5q...ermatology
FEIC: 78.14 (+0.79)
Verisante Obtains Mexican Approval
Marketwired - Thu Mar 12, 9:02AM CDT
Verisante Technology, Inc. (TSX VENTURE: VRS)(OTCQX: VRSEF) (the "Company" or "Verisante"
, a leader in skin cancer detection technology, announced today that it has received regulatory approval from the Federal Commission for Protection against Sanitary Risks (COFEPRIS), a division within the Mexican Ministry of Health, to market and sell Aura(TM), a device for the detection of skin cancer, in Mexico. VRS.VN: 0.100 (+0.010)
Verisante Technology, Inc. Announces Equipment Loan to Further Collaboration With Key Chinese Laboratory
Marketwired - Wed Feb 18, 9:01AM CST
Verisante Technology, Inc. (TSX VENTURE: VRS)(OTCQX: VRSEF) (the "Company" or "Verisante"
, a leader in cancer detection technology, announced today it has expanded its collaboration with Fujian Normal University in China (the "University" . VRS.VN: 0.100 (+0.010)
Verisante Technology, Inc. Announces Brain Tumour Study in the UK
Marketwired - Tue Jan 13, 8:30AM CST
Verisante Technology, Inc. (TSX VENTURE: VRS)(OTCQX: VRSEF) (the "Company" or "Verisante"
, a leader in cancer detection technology, announced today it has entered into a collaboration with the BC Cancer Agency and Imperial College Healthcare NHS Trust to develop a new application for the Company's exclusively licensed platform technology. VRS.VN: 0.100 (+0.010)
Verisante Technology, Inc. Announced Non-Brokered Private Placement and Year End Operational Update
Marketwired - Wed Dec 31, 8:31AM CST
Verisante Technology, Inc. (TSX VENTURE: VRS)(OTCQX: VRSEF) (the "Company" or "Verisante"
, a leader in cancer detection technology, today announced it has closed a non-brokered private placement of 3,888,889 common shares at a price of $0.09 per share for gross proceeds of $350,000. VRS.VN: 0.100 (+0.010)
North American Dermatology Diagnostic Devices Market Report 2014
M2 - Wed Dec 17, 6:32AM CST
Research and Markets (http://www.researchandmarkets.com/research/ddkrdp/micro_market) has announced the addition of the "Micro Market Monitor: North American Dermatology Diagnostic Devices Market" report to their offering. North America is considered to be the largest market in the dermatology diagnostic devices market segment, which is anticipated to grow at a CAGR of 9.6% from 2012 to 2013. Cosmetic surgeries and dermatological treatment is progressing steadily, which has resulted in fueling the overall demand of the dermatology diagnostic devices market. The main purpose of these dermatology devices is to assist in identifying and monitoring a patient's skin condition. With the growing awareness of skin disorders among the recent population, there is a rising incidence of dermatological procedures in the market. This has significantly laid a positive impact on the growing dependence of these innovative dermatological diagnostic techniques. The growing incidence of non-invasive aesthetic procedures have progressed the demand of dermatological diagnostic devices market in North America. Several other factors that have added to this growing demand are the prevalence of skin disorders, such as several tanning issues caused due to sun exposure, skin cancer, psoriasis, varicose veins, pigmentation, and vascular lesions. Advancements made in the field of dermatology have also resulted in the emergence of state-of-the-art diagnostic devices that deliver quick and accurate results. This huge demand of highly sophisticated diagnostic devices required to effectively examine patients and recommend necessary treatment measures have further influenced the North America dermatology diagnostic devices market to a large extent. Key Topics Covered: 1. Executive Summary 2. Introduction 3. Research Methodology 4. Market Overview 5. U.S. Dermatology Diagnostic Devices By Types 6. U.S. Dermatology Treatmetn Devices By Types 7. Company Profiles - Alma Lasers, Ltd. - Ambicare Health Ltd. - Amd Global Telemedicine Inc - Applisonix Ltd - Biolitec Ag - Carl Zeiss - Cutera, Inc. - Cynosure, Inc. - Ellipse A/S - Fei Company - Fotofinder Systems Gmbh - Genesis Biosystems - Leica Microsystems - Lumenis Ltd. - Michelson Diagnostics Ltd. - Nikon Corporation - Mela Sciences, Inc. - Verisante Technology, Inc. - Syneron Medical Ltd. - Heine Optotechnik - Solta Medical, A Division Of Valeant Pharmaceuticals North America, Llc. - Photomedex, Inc. For more information visit http://www.researchandmarkets.com/research/dd...cro_market
ELOS: 11.76 (-0.19), CYNO: 35.65 (+0.28), LMNS: 11.15 (-0.02)
Verisante Technology, Inc. to Present at 2nd Emerging Medical Technologies (EMT) Summit
Marketwired - Mon Nov 10, 9:01AM CST
Verisante Technology, Inc. (TSX VENTURE: VRS)(OTCQX: VRSEF) (the "Company" or "Verisante"
, a leader in cancer detection technology, today announced that Thomas Braun, President & CEO, will present at the upcoming Emerging Medical Technologies (EMT) Summit in San Francisco on November 11, 2014 at the Sofitel Hotel San Francisco Bay. VRS.VN: 0.100 (+0.010)
Verisante Technology, Inc. Announces Non Brokered Private Placement
Marketwired - Wed Oct 15, 11:36AM CDT
Verisante Technology, Inc. (TSX VENTURE: VRS)(OTCQX: VRSEF) (the "Company" or "Verisante"
, a leader in cancer detection technology, announced today it has closed a non-brokered private placement of 2,500,000 common shares at a price of $0.14 per share for gross proceeds of $350,000. VRS.VN: 0.100 (+0.010)
Verisante Technology, Inc. Announces Submission to the FDA for Aura(TM), a Skin Cancer Detection Device
Marketwire - Wed Oct 01, 9:01AM CDT
Verisante Technology, Inc. (TSX VENTURE: VRS)(OTCQX: VRSEF) (the "Company" or "Verisante"
, a leader in cancer detection technology, announced today it has initiated communications with the Food and Drug Administration ("FDA" in the United States for the approval of Aura(TM), a device for the detection of skin cancer. VRS.VN: 0.100 (+0.010)
Verisante Technology, Inc. Announces Re-Negotiated Letter of Intent for Equity Stake in Chinese Company
Marketwire - Tue Sep 30, 9:01AM CDT
Verisante Technology, Inc. (TSX VENTURE: VRS)(OTCQX: VRSEF) (the "Company" or "Verisante"
, a leader in cancer detection technology, announced today it has renegotiated a Letter of Intent between the Company and strategic partner (the "Partner" in the People's Republic of China, which terms were previously announced on June 25, 2014. VRS.VN: 0.100 (+0.010)
